بررسي تراكم استخوان در مبتلايان به آرتريت روماتوييد

Bone Mass Density in Rheumatoid Arthrithis Patients Treated with Glucocorticoide

Osteoporosis is common in rheumatoid arthritis. Corticoesteroids act as an independent risk factor for osteoporosis. We have evaluated the effect of glucocorticoids on bone density of patients with rheumatoid arthritis. In this study bone mass density of spine and neck of femur in 52 patients with rheumatoid arthritis who had been taking glucocorticoids for at least 6 months were compared with 17 control patients that not used glucocorticoids. Dual energy X-ray absorbiometry was used. Bone mass density was lower in spine and neck of femur in esteroid receiving patients in both sexes. This difference was statically significant only in femur of male patients. Decreased bone density was more significant in spine. There was no correlation between density of spine and femur. All patients with rheumatoid arthritis who were taking esteroid have more chance of osteoporosis and should be evaluated and followed by bone densitometry.